"Établissement public de santé, l’Hôpital de Saverne offre au cœur de la zone de proximité de Saverne : - une permanence d’accueil et de soins 24h/24 - un ensemble complet de services de haute technicité - un personnel qualifié et compétent garant de jour comme de nuit de la sécurité des patients."

During the past decade, Saverne - CH conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Saverne - CH" are "ALK Gene Mutation" (1 trials), "BRAF Gene Mutation" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "KRAS Gene Mutation" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Saverne - CH" in a lesser frequency.

Most popular intervention types in "Saverne - CH" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Experimental Treatment (PCDE or PE + bevacizumab)" (1 trials), "Prerandomization Chemotherapy (PCDE or PE)" (1 trials) and "Standard Chemotherapy (PCDE or PE)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saverne - CH" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Saverne - CH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Saverne - CH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Saverne - CH, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".